BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1823 related articles for article (PubMed ID: 23674658)

  • 21. Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?
    Viti A; Terzi A; Bianchi A; Bertolaccini L
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):129-34. PubMed ID: 24648467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.
    Viti A; Bertolaccini L; Cavallo A; Fortunato M; Bianchi A; Terzi A
    Eur J Cardiothorac Surg; 2014 Sep; 46(3):369-74; discussion 374. PubMed ID: 24585679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between tumor glucose metabolism and multiparametric functional MRI (IVIM and R2*) metrics in cervical carcinoma: Evidence from integrated
    Li-Ou Z; Hong-Zan S; Xiao-Xi B; Zhong-Wei C; Zai-Ming L; Jun X; Qi-Yong G
    J Magn Reson Imaging; 2019 Jun; 49(6):1704-1712. PubMed ID: 30390401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.
    Endo M; Nakagawa K; Ohde Y; Okumura T; Kondo H; Igawa S; Nakamura Y; Tsuya A; Murakami H; Takahashi T; Yamamoto N; Ito I; Kameya T
    Lung Cancer; 2008 Sep; 61(3):350-5. PubMed ID: 18304691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
    Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
    Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.
    Terzi A; Bertolaccini L; Rizzardi G; Luzzi L; Bianchi A; Campione A; Comino A; Biggi A
    Lung Cancer; 2011 Nov; 74(2):239-43. PubMed ID: 21439670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Superiority of [
    Shen X; Zhou X; Yao Y; Meng X; Song Y; Yang Z; Li N
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3414-3424. PubMed ID: 37316675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Associations Between [
    Surov A; Meyer HJ; Höhn AK; Winter K; Sabri O; Purz S
    Mol Imaging Biol; 2019 Apr; 21(2):368-374. PubMed ID: 29931433
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
    Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
    Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of [18F]fluoro-2-deoxy-D-glucose positron emission tomography for predicting the World Health Organization malignancy grade of thymic epithelial tumors.
    Igai H; Matsuura N; Tarumi S; Chang SS; Misaki N; Go T; Ishikawa S; Yokomise H
    Eur J Cardiothorac Surg; 2011 Jul; 40(1):143-5. PubMed ID: 20951602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.
    Thomas de Montpréville V; Quilhot P; Chalabreysse L; De Muret A; Hofman V; Lantuéjoul S; Parrens M; Payan MJ; Rouquette I; Secq V; Girard N; Besse B; Marx A; Molina TJ
    Pathol Res Pract; 2015 Dec; 211(12):996-1002. PubMed ID: 26534878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography.
    Bos R; van Der Hoeven JJ; van Der Wall E; van Der Groep P; van Diest PJ; Comans EF; Joshi U; Semenza GL; Hoekstra OS; Lammertsma AA; Molthoff CF
    J Clin Oncol; 2002 Jan; 20(2):379-87. PubMed ID: 11786564
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological correlation of ¹⁸F-FDG uptake on PET in pulmonary neuroendocrine tumors.
    Kaira K; Murakami H; Endo M; Ohde Y; Naito T; Kondo H; Nakajima T; Yamamoto N; Takahashi T
    Anticancer Res; 2013 Oct; 33(10):4219-28. PubMed ID: 24122985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymic epithelial tumors: Can fluorodeoxyglucose positron emission tomography help in predicting histologic type and stage?
    Purandare NC; Pramesh CS; Karimundackal G; Jiwnani S; Agrawal A; Shah S; Agarwal JP; Prabhash K; Noronha V; Joshi A; Kumar R; Rangarajan V
    Indian J Cancer; 2016; 53(2):270-273. PubMed ID: 28071625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.
    van Baardwijk A; Dooms C; van Suylen RJ; Verbeken E; Hochstenbag M; Dehing-Oberije C; Rupa D; Pastorekova S; Stroobants S; Buell U; Lambin P; Vansteenkiste J; De Ruysscher D
    Eur J Cancer; 2007 Jun; 43(9):1392-8. PubMed ID: 17512190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic activity on [18f]-fluorodeoxyglucose-positron emission tomography/computed tomography and glucose transporter-1 expression might predict clinical outcomes in patients with limited disease small-cell lung cancer who receive concurrent chemoradiation.
    Lee J; Kim JO; Jung CK; Kim YS; Yoo IeR; Choi WH; Jeon EK; Hong SH; Chun SH; Kim SJ; Kim YK; Kang JH
    Clin Lung Cancer; 2014 Mar; 15(2):e13-21. PubMed ID: 24368212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-inducible factor-1α, adrenomedullin and Bcl-2 although expected are not related to increased uptake of fluorine-18-fluorodeoxyglucose in endometrial cancer.
    Cerci SS; Yalcin Y; Bozkurt KK; Erdemoglu E; Tatar B; Erdemoglu E
    Hell J Nucl Med; 2015; 18(3):228-32. PubMed ID: 26637502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between expression of biological markers and [F]fluorodeoxyglucose uptake in endometrial cancer.
    Jo MS; Choi OH; Suh DS; Yun MS; Kim SJ; Kim GH; Jeon HN
    Oncol Res Treat; 2014; 37(1-2):30-4. PubMed ID: 24613906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and prognostic values of 2-[
    Han S; Kim YI; Oh JS; Seo SY; Park MJ; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
    Eur Radiol; 2022 Feb; 32(2):1173-1183. PubMed ID: 34448035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.